OtherResearch
Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing
Jeffrey Weber, James Hauschild, Pieta IJzerman-Boon, Ren-Yo Forng, Jeff Horsch, Lisa Yan, Aditya Prasad, Robert 'Bo' Henry, Marja Claassen, Philip Villari, Shebeer Shereefa, Jane Wyatt, Jay S. Bolden, Jean-Thierry Pycke and Dawood Dassu
PDA Journal of Pharmaceutical Science and Technology October 2018, pdajpst.2018.008722; DOI: https://doi.org/10.5731/pdajpst.2018.008722
Jeffrey Weber
1 Pfizer;
James Hauschild
2 Johnson & Johnson;
Pieta IJzerman-Boon
3 Merck (Merck, Sharp & Dohme outside the US and Canada);
Ren-Yo Forng
4 Amgen;
Jeff Horsch
5 Bristol-Myers Squibb;
Lisa Yan
6 Shire;
Aditya Prasad
7 AstraZeneca;
Robert 'Bo' Henry
8 Catalent Biologics;
Marja Claassen
3 Merck (Merck, Sharp & Dohme outside the US and Canada);
Philip Villari
3 Merck (Merck, Sharp & Dohme outside the US and Canada);
Shebeer Shereefa
9 Abbvie;
Jane Wyatt
10 Alexion;
Jay S. Bolden
11 Eli Lilly and Company;
Jean-Thierry Pycke
12 GSK Vaccines;
Dawood Dassu
13 BioPhorum
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing
Jeffrey Weber, James Hauschild, Pieta IJzerman-Boon, Ren-Yo Forng, Jeff Horsch, Lisa Yan, Aditya Prasad, Robert 'Bo' Henry, Marja Claassen, Philip Villari, Shebeer Shereefa, Jane Wyatt, Jay S. Bolden, Jean-Thierry Pycke, Dawood Dassu
PDA Journal of Pharmaceutical Science and Technology Oct 2018, pdajpst.2018.008722; DOI: 10.5731/pdajpst.2018.008722
Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing
Jeffrey Weber, James Hauschild, Pieta IJzerman-Boon, Ren-Yo Forng, Jeff Horsch, Lisa Yan, Aditya Prasad, Robert 'Bo' Henry, Marja Claassen, Philip Villari, Shebeer Shereefa, Jane Wyatt, Jay S. Bolden, Jean-Thierry Pycke, Dawood Dassu
PDA Journal of Pharmaceutical Science and Technology Oct 2018, pdajpst.2018.008722; DOI: 10.5731/pdajpst.2018.008722
Jump to section
Related Articles
- No related articles found.
Cited By...
- Challenges Encountered in the Implementation of Bio-Fluorescent Particle Counting Systems as a Routine Microbial Monitoring Tool
- A Discussion on Bio-Fluorescent Particle Counters: Summary of the Process and Environmental Monitoring Methods Working Group Meeting with the FDA Emerging Technology Team
- Environmental and Personnel Monitoring Programs--A Risk-Based Case Study of Cutibacterium acnes
- Practical Applications of Biofluorescent Particle Counting in Environmental Monitoring Investigations
More in this TOC Section
Similar Articles